Objective: To determine whether ALS patients' preferences for ameliorative
or life-extending technologies elicited early in the disease were related t
o later treatment choices. Methods: In this prospective cohort study, 121 p
atients were seen at a tertiary ALS care center and followed for a median o
f 12 months. At baseline, patient preferences for use of tracheostomy and p
ercutaneous endoscopic gastrostomy (PEG) placement were elicited. All patie
nts received the same educational information before being interviewed abou
t treatment preferences. Patients were then followed to determine if patien
ts who viewed the interventions favorably at baseline were significantly mo
re likely to use the interventions over follow-up. Results: Six to twelve p
ercent of patients were certain they wanted tracheostomy and 28.2% wanted P
EG. Preferences were related to later treatment choices: 20% of patients wh
o found tracheostomy acceptable had one in the follow-up period, compared w
ith 3.4% of those not in favor (p < 0.001). For PEG, similar findings were
obtained: 48.5% who initially found it acceptable had PEG, versus 8.1% of t
hose not in favor of this treatment (p < 0.001). Patients who found the int
erventions acceptable were more likely to be recently diagnosed, expressed
greater attachment to life, and showed greater declines in pulmonary functi
on over follow-up. Conclusions: Patients with ALS were able to express thei
r preferences for life-extending or ameliorative technologies and made choi
ces consistent with these preferences. However, patient preferences may cha
nge over time, and clinical education efforts are required throughout the c
ourse of disease.